Daten und Fakten 2011 - Universitätsspital Basel

88
Bereich Medizin
Ausgewählte Publikationen
1. Heuss LT, Hanhart A, Dell-Kuster S, Zdrnja K, Ortmann M, Beglinger C, Bucher
HC, Degen L. Propofol sedation alone or in combination with pharyngeal
lidocaine anesthesia for routine upper GI endoscopy: a randomized, double-blind,
placebo-controlled, non-inferiority trial.
Gastrointest Endosc. 2011 Dec;74(6):1207-14. Epub 2011 Oct 13.
2. Langhans W, Beglinger C, Woods SC. Introduction to „The intestinal wall - The
regulatory interface in energy homeostasis“.
Physiol Behav. 2011 Nov 30;105(1):1-3.
3. Gerspach AC, Steinert RE, Schönenberger L, Graber-Maier A, Beglinger C. The
role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in
humans.
Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E317-25.
4. Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C.
Effects of postbariatric surgery weight loss on adipokines and metabolic
parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic
sleeve gastrectomy—a prospective randomized trial.
Surg Obes Relat Dis. 2011 Sep;7(5):561-8.
5. Steinert RE, Beglinger C. Nutrient sensing in the gut: interactions between
chemosensory cells, visceral afferents and the secretion of satiation peptides.
Physiol Behav. 2011 Nov 30;105(1):62-70.
6. Steinert RE, Gerspach AC, Gutmann H, Asarian L, Drewe J, Beglinger C. The
functional involvement of gut-expressed sweet taste receptors in glucosestimulated
secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY).
Clin Nutr. 2011 Aug;30(4):524-32. Epub 2011 Feb 15.
7. Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, Schoepfer A,
Simon HU. Long-term budesonide maintenance treatment is partially effective
for patients with eosinophilic esophagitis.
Clin Gastroenterol Hepatol. 2011 May;9(5):400-9.e1. Epub 2011 Jan 28.
8. Steinert RE, Frey F, Töpfer A, Drewe J, Beglinger C. Effects of carbohydrate sugars and
artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides.
Br J Nutr. 2011 May;105(9):1320-8.
9. Lange CM, Kutalik Z, Morikawa K, Bibert S, Cerny A, Dollenmaier G, Dufour JF,
Gerlach TJ, Heim MH, Malinverni R, Müllhaupt B, Negro F, Moradpour D,
Bochud PY; the Swiss Hepatitis C Cohort Study Group. Serum ferritin levels are
associated with a distinct phenotype of chronic hepatitis C poorly responding to
pegylated interferon- and ribavirin therapy.
Hepatology. 2011 Nov 16. doi: 10.1002/hep.24787. [Epub ahead of print]